APOE and neurodegenerative disease: This cohort is enriched for non-Hispanic Caucasian patients, patients of higher socioeconomic status, patients with higher education, patients with rare neurodegenerative diseases and more severe neuropathologic findings and clinical symptoms, and patients with more frequent APOE ε4 alleles compared to community-based autopsy cohorts.